Theracryf
Financial ratios & Valuation

Historical Multiples (2017 – 2022)

2017 2019 2020 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.30-6.75-1.72-3.52N/A-4.24
Price/Sales ratio
N/AN/AN/AN/AN/AN/A
Price/Book Value ratio
3.848.541.111.04N/A4.82
Price/Cash Flow ratio
-5.09-7.75-1.81-3.75N/A-4.78
Price/Free Cash Flow ratio
-4.98-7.75-1.81-3.75N/A-4.78
Price/Earnings Growth ratio
N/A0.410.070.07N/A0.24
Dividend Yield
N/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A
Effective Tax Rate
15.80%15.89%14.24%13.85%N/A15.07%
Return on Assets
-64.69%-94.93%-55.89%-28.32%N/A-75.41%
Return On Equity
-72.56%-126.39%-64.58%-29.58%N/A-95.48%
Return on Capital Employed
-86.18%-150.28%-74.83%-34.58%N/A-112.56%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A
Quick Ratio
8.953.867.3023.30N/A5.58
Cash ratio
7.502.956.3210.97N/A4.64
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
3.52K9.24K8.96K1.50KN/A9.10K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.121.331.151.04N/A1.24
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.0211.001.00N/A1.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/A